Author: Mak Yuen Teen

By Mak Yuen Teen On July 5, I posted an article “Biolidics’ Disclosures Are Simply Unacceptable” in which I questioned why Biolidics did not timely disclose the fact that its exclusive distribution agreement...

The report covers board governance, remuneration, risk management and emerging trends (corporate culture, sustainability, technological disruption and cybersecurity) among 50 of the largest listed banks and 50 of the largest listed insurance companies in Asia-Pacific.

By Mak Yuen Teen On July 14, 10.46 pm, Biolidics announced a five-year non-exclusive licensing agreement with Accelerate Technologies Pte Ltd (A*ccelerate), the commercialisation arm of A*STAR. The announcement said that the...